Matches in Nanopublications for { ?s ?p "[The position of the mutations and the loss of heterozygosity of MAP3K5 and MAP3K9 in 85% and 67% of melanoma samples, respectively, together suggest that the mutations are likely to be inactivating.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP808160.RAYqyH-Yvh7e7KOEhHdBlr7RXYq36V6gGgxr21rRPpYEk130_assertion description "[The position of the mutations and the loss of heterozygosity of MAP3K5 and MAP3K9 in 85% and 67% of melanoma samples, respectively, together suggest that the mutations are likely to be inactivating.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808160.RAYqyH-Yvh7e7KOEhHdBlr7RXYq36V6gGgxr21rRPpYEk130_provenance.
- NP768394.RA7f-CPdLJ0L3AirkQcq4U1VMPGAI9pyMnPKyrlUnFr78130_assertion description "[The position of the mutations and the loss of heterozygosity of MAP3K5 and MAP3K9 in 85% and 67% of melanoma samples, respectively, together suggest that the mutations are likely to be inactivating.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768394.RA7f-CPdLJ0L3AirkQcq4U1VMPGAI9pyMnPKyrlUnFr78130_provenance.
- NP21495.RArSkvTQqEVIa_KzKc0mpaRiAxFo-MZdfeZf09gcRyzkg130_assertion description "[The position of the mutations and the loss of heterozygosity of MAP3K5 and MAP3K9 in 85% and 67% of melanoma samples, respectively, together suggest that the mutations are likely to be inactivating.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21495.RArSkvTQqEVIa_KzKc0mpaRiAxFo-MZdfeZf09gcRyzkg130_provenance.
- assertion description "[The position of the mutations and the loss of heterozygosity of MAP3K5 and MAP3K9 in 85% and 67% of melanoma samples, respectively, together suggest that the mutations are likely to be inactivating.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The position of the mutations and the loss of heterozygosity of MAP3K5 and MAP3K9 in 85% and 67% of melanoma samples, respectively, together suggest that the mutations are likely to be inactivating.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP949137.RAQukakDaNumialbGP4y05zxNNwxABEtSzvaevfTzLkCc130_assertion description "[The position of the mutations and the loss of heterozygosity of MAP3K5 and MAP3K9 in 85% and 67% of melanoma samples, respectively, together suggest that the mutations are likely to be inactivating.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949137.RAQukakDaNumialbGP4y05zxNNwxABEtSzvaevfTzLkCc130_provenance.
- NP552943.RA5tyJVxrmM4W2-oyVtfyM8XQsYq1sgvHoRT68igylkwQ130_assertion description "[The position of the mutations and the loss of heterozygosity of MAP3K5 and MAP3K9 in 85% and 67% of melanoma samples, respectively, together suggest that the mutations are likely to be inactivating.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552943.RA5tyJVxrmM4W2-oyVtfyM8XQsYq1sgvHoRT68igylkwQ130_provenance.